BlackRock
IMA

BlackRock’s ImageneBio Inc IMA Stock Holding History

BlackRock’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$646K Sell
129,214
-2,373
-2% -$15.4K ﹤0.01% 4463
2025
Q4 		$908K Buy
131,587
+79,476
+153% +$589K ﹤0.01% 4330
2025
Q3 		$425K Buy
52,111
+22,283
+75% +$295K ﹤0.01% 4498
2025
Q2 		$480K Buy
29,828
+775
+3% +$11.4K ﹤0.01% 4454
2025
Q1 		$446K Sell
29,053
-292
-1% -$5.04K ﹤0.01% 4427
2024
Q4 		$578K Sell
29,345
-3
-0% -$61 ﹤0.01% 4371
2024
Q3 		$609K Sell
29,348
-222
-0.8% -$4.49K ﹤0.01% 4284
2024
Q2 		$585K Sell
29,570
-122,826
-81% -$2.17M ﹤0.01% 4304
2024
Q1 		$2.6M Sell
152,396
-2,450
-2% -$44.6K ﹤0.01% 3905
2023
Q4 		$3.66M Buy
154,846
+34,330
+28% +$1.12M ﹤0.01% 3814
2023
Q3 		$6.26M Buy
120,516
+14,904
+14% +$897K ﹤0.01% 3577
2023
Q2 		$8.31M Buy
105,612
+80,009
+312% +$5.74M ﹤0.01% 3499
2023
Q1 		$1.06M Buy
25,603
+152
+0.6% +$6.99K ﹤0.01% 4321
2022
Q4 		$812K Sell
25,451
-16,395
-39% -$524K ﹤0.01% 4474
2022
Q3 		$1.78M Buy
41,846
+17,867
+75% +$1.03M ﹤0.01% 4245
2022
Q2 		$1.27M Sell
23,979
-100,451
-81% -$5.54M ﹤0.01% 4435
2022
Q1 		$9.11M Buy
124,430
+10,774
+9% +$1.15M ﹤0.01% 3629
2021
Q4 		$17.1M Buy
113,656
+73,328
+182% +$11.9M ﹤0.01% 3370
2021
Q3 		$6.11M Buy
40,328
+2,850
+8% +$414K ﹤0.01% 3876
2021
Q2 		$6.31M Buy
37,478
+30,226
+417% +$6.67M ﹤0.01% 3804
2021
Q1 		$2.46M Buy
+7,252
New +$2.48M ﹤0.01% 4226

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock's IMA Position: Q1 2026 in Review

BlackRock reduced its ImageneBio Inc (IMA) stake by 1.8% in Q1 2026, selling an estimated $15.4K and leaving 129,214 shares worth $646K. The position accounts for ﹤0.01% of the portfolio, ranked #4463.

BlackRock first reported a position in IMA in Q1 2021 and has held it in 21 quarters since. The position peaked at $17.1M in Q4 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • BlackRock held 129,214 shares of ImageneBio Inc worth $646K as of Q1 2026.
  • BlackRock sold 2,373 ImageneBio Inc shares in Q1 2026, an estimated $15.4K.
  • ImageneBio Inc made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4463 holding.
  • BlackRock first reported a position in ImageneBio Inc in Q1 2021 and has held it in 21 quarters since.
  • BlackRock's ImageneBio Inc position peaked at $17.1M in Q4 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.